Histological changes of cervical tumours following Zanthoxylum acanthopodium DC treatment, and its impact on cytokine expression.

Cervical cancer is the second most lethal cancer in Indonesia, behind breast cancer. One of the reasons cancer cells are difficult to treat is that the immune system is sometimes unable to recognise them as foreign. Cytokinin therapy is carried out so that the immune system can strengthen its response to cancer cells, with the aim of slowing or stopping the development of malignant cells. Zanthoxylum acanthopodium DC, also known as andaliman, is an Indonesian herb and a member of the Rutaceae family. It is rich in antioxidants and has anti-inflammatory and anti-cancer properties. The current study aimed to investigate the histological changes and changes in the expression of cytokines, such as IL-10, IL1ß, VEGFR1, and TGFß1, associated with andaliman treatment. Sample tissues and serums extracted from cervical cancer rat models were used. Rats were divided into five groups: a control group (C-), cancer model group (C+), cancer with a dose of Z. acanthopodium methanolic extract (ZAM) 100 mg/body weight (BW) ZAM (ZAM100), cancer with a dose of ZAM 200 mg/BW ZAM (ZAM200), and cancer with a dose of ZAM 400 mg/BW ZAM (ZAM400). Treatment lasted for 1 month. Blood samples were prepared for ELISA analysis, and cervical tissue was stained for immunohistochemistry using antibodies against IL-10, IL-1ß, VEGFR1, and TGFß1. Administration of ZAM had no significant effect on rat body weight and cervical organs (p > 0.05). However, it impacted haematological parameters in rats with cervical cancer (p < 0.05). Elevated malondialdehyde levels may be linked to superoxide dismutase deficiency in tumour tissue. ZAM significantly decreased the expression of IL1ß, TGFß1, and VEGFR1 (p < 0.01), while it increased the expression of IL-10. Therefore, ZAM may be a potential target for molecular cytokine therapy for cervical cancer.

PDGF-ß and IL-18 Expressions on Carcinoma Cervical by Rhodomyrtus tomentosa.

<b>Background and Objective:</b> Cervical cancer, along with lung and breast cancer, is one of Indonesia's most aggressive gynaecological diseases. <i>Rhodomyrtus tomentosa</i> has antioxidant and antiproliferative properties that could be developed into herbal medicines for molecular therapy. The IL-18 and PDGF-ß are tumour-promoting agent proteins that may be therapeutic targets for a variety of cancers that were investigated in this study. <b>Materials and Methods:</b> Rats were classified into five groups: Group C- is the control group, Group C+ is the cancer model group and Group RHO200 is the <i>Rhodomyrtus tomentosa</i> 100 mg¹ b.wt., rat group, Group RHO400 is the <i>Rhodomyrtus tomentosa</i> 200 mg¹ b.wt., rat group and Group RHO400 is the <i>Rhodomyrtus tomentosa</i> 400 mg¹ b.wt., rat group. The rats were dissected 30 days after receiving <i>Rhodomyrtus tomentosa</i>. Immunohistochemistry is used to stain cervical tissues. <b>Results:</b> The expression of IL-18 and PDGF-ß was significantly different (p<0.01). The IL-18 and PDGF-ß were most abundant at the lowest <i>Rhodomyrtus tomentosa</i> doses (100-200 mg kg¹ b.wt.), while they were least abundant at the 400 mg kg¹ b.wt., doses. Histological analysis revealed that the highest dose of IL-18 and PDGF-ß expression reduced abnormal tissue and the space between tumours, followed by several carcinoma cells that stopped growing. <b>Conclusion:</b> <i>Rhodomyrtus tomentosa</i> can be used as a herbal therapy to reduce the expression of PDGF-ß and IL-18 (two cancer marker agents).

Correlation of Myc Expression with Wee1 Expression by Zanthoxylum acanthopodium in Cervical Carcinoma Histology.

<b>Background and Objective:</b> Natural herbs and molecular therapy can be used to treat cervical cancer. The Myc and Wee1 control tumour cell fate and microenvironmental changes like angiogenesis activation and host immune response suppression. The study aims to know about the correlation of Myc and Wee1 expressions as a molecular therapy given by <i>Zanthoxylum acanthopodium</i>. <b>Materials and Methods:</b> There are five rat groups: Group K is the untreated group, Group K⁺ is the rats injected with benzopyrene, Group P₁ is the administration of <i>Zanthoxylum acanthopodium</i> 100 mg kg¹ b.wt., Group P₂ is the administration of <i>Zanthoxylum acanthopodium</i> 200 mg kg¹ b.wt. and Group P₃ is the administration of <i>Zanthoxylum acanthopodium</i> 400 mg kg¹ b.wt. The rats are dissected 30 days after receiving <i>Zanthoxylum acanthopodium</i>. To stain the cervical tissues, immunohistochemistry is performed. <b>Results:</b> <i>Zanthoxylum acanthopodium</i> administration caused epithelial thickening and decreased Myc expression in previously uncontrolled carcinomas from untreated malignancies, which now slowed and stopped growing into the normal epithelium. Wee1 expression revealed that this herb could repair tissue by drastically reducing Wee1 expression at a dose of 100-400 mg kg¹ b.wt. Similarly, at the highest dose, cervical carcinoma stops growing and the nucleus begins to form normally (p<0.01). <b>Conclusion:</b> The higher Myc expression on andaliman administration in cervical carcinoma decreases Wee1 expression in cervical carcinoma so these two proteins have a strong and significant correlation. <i>Zanthoxylum acanthopodium</i> can be administered at various dosages to lower the number of positive indexes of Myc and Wee1 expression in cervical carcinoma.